Invesco Ltd. Karyopharm Therapeutics Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Invesco Ltd. holds 58,152 shares of KPTI stock, worth $48,847. This represents 0.0% of its overall portfolio holdings.

Number of Shares

58,152

Previous 40,511 43.55%

Holding current value

$48,847

Previous $35,000 37.14%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$0.7 - $1.06 $12,348 - $18,699	17,641 Added 43.55%	58,152 $48,000
Q2 2024 Aug 13, 2024	BUY	$0.87 - $1.58 $10,911 - $19,816	12,542 Added 44.84%	40,511 $35,000
Q1 2024 May 14, 2024	SELL	$0.72 - $1.66 $361 - $833	-502 Reduced 1.76%	27,969 $42,000
Q4 2023 Feb 12, 2024	SELL	$0.68 - $1.31 $24,031 - $46,296	-35,341 Reduced 55.38%	28,471 $24,000
Q3 2023 Nov 13, 2023	BUY	$1.14 - $1.81 $10,568 - $16,780	9,271 Added 17.0%	63,812 $85,000
Q2 2023 Aug 11, 2023	BUY	$1.79 - $4.59 $20,248 - $51,922	11,312 Added 26.17%	54,541 $97,000
Q1 2023 May 12, 2023	BUY	$2.84 - $3.92 $20,172 - $27,843	7,103 Added 19.66%	43,229 $168,000
Q4 2022 Feb 13, 2023	BUY	$2.48 - $5.93 $3,038 - $7,264	1,225 Added 3.51%	36,126 $122,000
Q3 2022 Nov 14, 2022	BUY	$4.08 - $5.82 $15,528 - $22,150	3,806 Added 12.24%	34,901 $191,000
Q2 2022 Aug 15, 2022	SELL	$4.15 - $8.37 $1,871 - $3,774	-451 Reduced 1.43%	31,095 $141,000
Q1 2022 May 16, 2022	SELL	$5.91 - $14.38 $130 - $316	-22 Reduced 0.07%	31,546 $232,000
Q4 2021 Feb 14, 2022	SELL	$5.21 - $8.61 $13,488 - $22,291	-2,589 Reduced 7.58%	31,568 $203,000
Q3 2021 Nov 15, 2021	BUY	$4.45 - $10.63 $24,701 - $59,007	5,551 Added 19.41%	34,157 $199,000
Q2 2021 Aug 17, 2021	BUY	$8.11 - $11.11 $84,554 - $115,832	10,426 Added 57.35%	28,606 $295,000
Q1 2021 May 17, 2021	SELL	$9.85 - $17.69 $65,502 - $117,638	-6,650 Reduced 26.78%	18,180 $191,000
Q4 2020 Feb 16, 2021	BUY	$14.15 - $17.19 $143,650 - $174,512	10,152 Added 69.16%	24,830 $385,000
Q3 2020 Nov 16, 2020	SELL	$14.14 - $19.71 $2,248 - $3,133	-159 Reduced 1.07%	14,678 $215,000
Q2 2020 Aug 14, 2020	SELL	$16.6 - $25.25 $1.15 Million - $1.75 Million	-69,202 Reduced 82.35%	14,837 $281,000
Q1 2020 May 15, 2020	SELL	$14.38 - $27.72 $2.17 Million - $4.17 Million	-150,580 Reduced 64.18%	84,039 $1.61 Million
Q4 2019 Feb 14, 2020	SELL	$9.23 - $19.67 $413,005 - $880,153	-44,746 Reduced 16.02%	234,619 $4.5 Million
Q3 2019 Nov 14, 2019	BUY	$5.66 - $11.85 $1.58 Million - $3.31 Million	279,365 New	279,365 $2.69 Million

Others Institutions Holding KPTI

# of Institutions

Shares Held

57.6M

Call Options Held

258K

Put Options Held

81.2K

View Full List

About Karyopharm Therapeutics Inc.

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $67M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

More about KPTI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account